Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Oak Ridge Investments LLC

Oak Ridge Investments LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,060 shares of the medical equipment provider’s stock after purchasing an additional 698 shares during the quarter. Oak Ridge Investments LLC’s holdings in Intuitive Surgical were worth $4,942,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Reston Wealth Management LLC acquired a new position in shares of Intuitive Surgical during the third quarter valued at $205,000. Fairfield Financial Advisors LTD grew its position in Intuitive Surgical by 22.1% in the 3rd quarter. Fairfield Financial Advisors LTD now owns 3,276 shares of the medical equipment provider’s stock worth $1,609,000 after purchasing an additional 594 shares during the last quarter. AustralianSuper Pty Ltd increased its stake in shares of Intuitive Surgical by 9.7% in the third quarter. AustralianSuper Pty Ltd now owns 12,886 shares of the medical equipment provider’s stock valued at $6,331,000 after purchasing an additional 1,140 shares during the period. Congress Asset Management Co. raised its holdings in shares of Intuitive Surgical by 0.9% during the third quarter. Congress Asset Management Co. now owns 307,266 shares of the medical equipment provider’s stock valued at $150,951,000 after buying an additional 2,868 shares during the last quarter. Finally, Catalyst Financial Partners LLC grew its holdings in Intuitive Surgical by 4.8% in the 3rd quarter. Catalyst Financial Partners LLC now owns 1,852 shares of the medical equipment provider’s stock worth $910,000 after buying an additional 85 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $503.84 on Friday. Intuitive Surgical, Inc. has a 52-week low of $260.17 and a 52-week high of $523.34. The company has a market cap of $179.46 billion, a P/E ratio of 81.00, a P/E/G ratio of 5.05 and a beta of 1.39. The stock’s 50-day moving average is $490.01 and its 200-day moving average is $445.70.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 240 shares of the stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,558,968.56. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, General Counsel Gary Loeb sold 300 shares of Intuitive Surgical stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the transaction, the general counsel now directly owns 1,595 shares of the company’s stock, valued at $757,625. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,558,968.56. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 68,246 shares of company stock valued at $33,839,308 in the last three months. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent analyst reports. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Barclays increased their price target on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research note on Thursday, July 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Finally, Truist Financial upped their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.